Topics

Articles

In an open letter, CEO Albert Bouria sought to give clarity to the drug’s development timeline.

Coronavirus: Pfizer CEO says company to seek EUA for vaccine after election

The trial had been halted due to a side-effect in an English patient.

Coronavirus: AstraZeneca/Oxford resumes vaccine trial

The pledge seeks to assuage fears that the Trump administration will rush a vaccine into production for political purposes.

Coronavirus: Drug executives pledge to ensure vaccine is safe

In a letter, the agency pushes states to fast-track permitting and licensing for possible distribution sites.

Report: CDC urges governors to be ready for coronavirus vaccine by November

The ACP says that staying up to date on vaccinations is more important than ever.

Flu season 2020: Physicians urge patients to get vaccinated

A trio of experts will discuss the prospects of a handful of COVID-19 vaccine candidates which are entering phase 3 trials.

MJH Life Sciences to host free webinar on COVID-19 vaccine progress

The deal is for the companies to supply up to 600 million doses of a MRNA-based vaccine candidate.

Coronavirus: Pfizer and BioNTech to supply vaccine candidate to U.S. government

The candidate is a joint effort of Oxford University and AstraZeneca.

Coronavirus: Oxford vaccine candidate boosts immune response

In a 45-person phase one clinical trial the vaccine subjects who received the vaccine candidate showed high neutralizing antibody responses.

Coronavirus: Vaccine candidate shows promise in trial

Rachael Zimlich is a freelance writer in Cleveland, Ohio. She writes regularly for Contemporary Pediatrics, Managed Healthcare Executive, and Medical Economics.

For people who love cats but are allergic to them, relief may be on the horizon-and cats, rather than humans, would be the ones to be vaccinated.

Vaccines